Aminopyrimidine derivatives as LRRK2 modulators
US8791130B2 · kind B2 · utility
11Cited by
1References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 28, 2012 |
| Grant date | Jul 29, 2014 |
| Priority date | — |
| Expiry date | Nov 28, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D239/48
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of the formula I:or pharmaceutically acceptable salts thereof,wherein m, n. X, R1, R2, R3, R4 and R5 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with LRRK2 receptor, such as Parkinson's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.